August Bioservices
PrivateLast Round
Grant
Oct 20, 2023
Total Funding Raised
$89.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
August Bioservices operates in Healthcare & Life Sciences and is based in Nashville, Tennessee. Its latest recorded funding round was a Grant round in October 2023.
August Bioservices is a pharmaceutical contract development and manufacturing organization (CDMO) that provides drug discovery, development, and manufacturing services for the pharmaceutical and biotechnology industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
August Bioservices Comparables
Compare August Bioservices with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| INCOG BioPharma Services | 90% | |
| Afton Scientific | 90% | |
| Grand River Aseptic Manufacturing | 89% |
For institutional investors. Book with your work email.
August Bioservices Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 20, 2023 | ||||
| Series B | Dec 1, 2022 | ||||
| Series A Extension | May 27, 2021 | ||||
| Series A | Jul 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
August Bioservices Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oak HC/FT | Series A, Series B, Series A Extension |
| Tennessee Department of Economic and Community Development | Grant |
| Polaris Partners | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 90% MoM.
- Jul 13, 2026
Investing significant capital in a two-phase expansion project, including a new facility.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- decreases_headcount_bySep 10, 2026
In Aug '26, August Bioservices LLC decreases its headcount by 500 jobs through layoffs, with job losses down 90% from the previous year.
For institutional investors. Book with your work email.
August Bioservices Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about August Bioservices's valuation, stock price, and market status.
Is August Bioservices a public or private company?
August Bioservices is a private company.
What is the current stock price of August Bioservices?
August Bioservices is a private company, so its shares have no public market price. Caplight tracks August Bioservices's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is August Bioservices worth (valuation)?
Valuation information for August Bioservices is not publicly available.
Can I buy August Bioservices stock?
August Bioservices shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was August Bioservices's last funding round?
August Bioservices's most recent funding round was Grant on October 20, 2023.
Who are the main investors in August Bioservices?
Key investors in August Bioservices include Oak HC/FT, Polaris Partners.
Will August Bioservices IPO soon?
No public IPO plans have been announced for August Bioservices.
How can I track August Bioservices secondary market activity?
Caplight tracks bids, offers, and trades in August Bioservices's shares on secondary markets.